Core Viewpoint - The article emphasizes the importance of long-term value investment strategies, encouraging investors to focus on core areas and maintain patience and foresight in their investment decisions [1][10]. Group 1: Investment Strategies - The executives from Guolianan Fund express their commitment to value investment, highlighting the need to capture long-term value rather than seeking short-term gains [1][2]. - The investment philosophy is likened to riding a fine horse, suggesting a steady and strategic approach to navigating market fluctuations [1][10]. Group 2: Product Highlights - Guolianan Fund presents several key products, including Guolianan Selected Mixed Fund (257020) and Guolianan Technology Power (001956), which focus on value investment and technology sectors [2][12]. - The Guolianan Fixed Income Department emphasizes a steady approach to bond investments, advocating for a long-term perspective to build safety margins [5][12]. Group 3: Executive Insights - The Chief Investment Officer, Wei Dong, encourages investors to adopt a long-term vision, wishing them success in the new year with a focus on sustainable growth [1][10]. - Other executives, such as Zong Xinjing and Pan Ming, highlight the importance of adapting to new market conditions and the potential of technology investments [2][12].

Group 1 - The ETF market showed mixed performance on the 7th, with the medical device ETF (159797) leading gains at 2.24% [2] - The Sci-Tech chip design ETF (588780) also saw an increase of 2.11%, along with the medical device index ETF (159898) which rose by 2.11% [2] - Conversely, the N-Hong Kong Stock Connect innovative drug ETF by Jiashi (520970) experienced the largest decline at 3.04%, followed by the Sci-Tech innovative drug ETF by Guotai (589720) which fell by 2.96%, and the Hong Kong Stock Connect innovative drug ETF by ICBC (159217) which dropped by 2.93% [2]